课题基金 / 基金详情

Medicines and Ageing

Medicines and Ageing
药物与衰老
批准号:
nhmrc : GNT1060407
负责人:
A/Pr Christopher Etherton-Beer
金额:
$244.65万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Centres of Research Excellence
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 --
关键词:

项目摘要

项目成果

A/Pr Christopher Etherton-Beer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Medicines have an important place in health and are commonly used for long periods, sometimes life-long. Using medicines wisely requires a careful balance between benefits and harmful effects. Currently, there is limited information to guide medicines use over a lifetime. Using large linked datasets, the CRE in Medicines and Ageing will generate much needed evidence about real world medicines use to support clinical and pharmaceutical policy decisions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.
  • 批准号:
    nhmrc : GNT1139616
  • 项目类别:
    Boosting Dementia Research Initiative
  • 资助金额:
    $58.68万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
BAN-Dep: A trial to decrease the prevalence of depression in Australian Nursing Homes
  • 批准号:
    nhmrc : 1150529
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $58.44万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
BAN-Dep: A trial to decrease the prevalence of depression in Australian Nursing Homes
  • 批准号:
    nhmrc : GNT1150529
  • 项目类别:
    Targeted Calls for Research
  • 资助金额:
    $86.43万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.
  • 批准号:
    nhmrc : 1139616
  • 项目类别:
    Targeted Calls
  • 资助金额:
    $39.68万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Christopher Etherton-Beer
  • 依托单位:
国内基金
海外基金
长非编码RNA Linc-RAM在Ageing导致的骨骼肌肌少症发生发展中的功能与分子机制